Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Experience of a single center using BFM protocols

Pediatr Blood Cancer. 2019 Jun;66(6):e27711. doi: 10.1002/pbc.27711. Epub 2019 Mar 13.

Authors

Evrim Çifçi Sunamak¹, Nihal Özdemir², Tiraje Celkan³

Affiliations

¹ Department of Pediatrics, Kartal Dr. Lütfi Kırdar Training and Research Hospital, İstanbul, Turkey.
² Division of Pediatric Hematology and Oncology, Department of Pediatrics, Kanuni Sultan Süleyman Training and Research Hospital, İstanbul, Turkey.
³ Division of Pediatric Hematology and Oncology, Department of Pediatrics, Cerrahpaşa Faculty of Medicine, İstanbul University, İstanbul, Turkey.

PMID: 30868749
DOI: 10.1002/pbc.27711

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Asparaginase
Child
Daunorubicin
Humans
Posterior Leukoencephalopathy Syndrome*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
Prednisone
Risk Factors
Vincristine

Substances

Vincristine
Asparaginase
Prednisone
Daunorubicin

Supplementary concepts

PVDA protocol